Side chain variations radically alter the diffusion of poly(2-alkyl-2-oxazoline) functionalised nanoparticles through a mucosal barrier by Mansfield, Edward DH et al.
Biomaterials
 Science
www.rsc.org/biomaterialsscience
ISSN 2047-4830
 PAPER 
 Vitaliy V. Khutoryanskiy  et al. 
 Side chain variations radically alter the diff usion of poly(2-alkyl-2-oxazoline) 
functionalised nanoparticles through a mucosal barrier 
Volume 4  Number 9  September 2016  Pages 1269–1404
Biomaterials
Science
PAPER
Cite this: Biomater. Sci., 2016, 4,
1318
Received 3rd June 2016,
Accepted 5th July 2016
DOI: 10.1039/c6bm00375c
www.rsc.org/biomaterialsscience
Side chain variations radically alter the diﬀusion of
poly(2-alkyl-2-oxazoline) functionalised
nanoparticles through a mucosal barrier†
Edward D. H. Mansﬁeld,a Victor R. de la Rosa,b Radoslaw M. Kowalczyk,c
Isabelle Grillo,d Richard Hoogenboom,b Katy Sillence,e Patrick Hole,e
Adrian C. Williamsa and Vitaliy V. Khutoryanskiy*a
Functionalised nanomaterials are gaining popularity for use as drug delivery vehicles and, in particular,
mucus penetrating nanoparticles may improve drug bioavailability via the oral route. To date, few poly-
mers have been investigated for their muco-penetration, and the eﬀects of systematic structural changes
to polymer architectures on the penetration and diﬀusion of functionalised nanomaterials through
mucosal tissue have not been reported. We investigated the inﬂuence of poly(2-oxazoline) alkyl side
chain length on nanoparticle diﬀusion; poly(2-methyl-2-oxazoline), poly(2-ethyl-2-oxazoline), and poly
(2-n-propyl-2-oxazoline) were grafted onto the surface of thiolated silica nanoparticles and characterised
by FT-IR, Raman and NMR spectroscopy, thermogravimetric analysis, and small angle neutron scattering.
Diﬀusion coeﬃcients were determined in water and in a mucin dispersion (using Nanoparticle Tracking
Analysis), and penetration through a mucosal barrier was assessed using an ex vivo ﬂuorescence tech-
nique. The addition of a single methylene group in the side chain signiﬁcantly altered the penetration and
diﬀusion of the materials in both mucin dispersions and mucosal tissue. Nanoparticles functionalised with
poly(2-methyl-2-oxazoline) were signiﬁcantly more diﬀusive than particles with poly(2-ethyl-2-oxazoline)
while particles with poly(2-n-propyl-2-oxazoline) showed no signiﬁcant increase compared to the
unfunctionalised particles. These data show that variations in the polymer structure can radically alter
their diﬀusive properties with clear implications for the future design of mucus penetrating systems.
1. Introduction
Over recent years, nanoparticles have gained concomitant
interest both in academia and industry as they provide unique
physicochemical properties not shown by bulk materials.1 Due
to their sub-micron size, they can exhibit quantum-like fea-
tures dependent on size, morphology, and bulk composition
of the material. Nanoparticles can be tuned and engineered to
have specific attributes for bespoke applications and can thus
have unique magnetic,2 optical,3 and physicochemical pro-
perties4 through appropriate surface functionalisation.
Poly(2-oxazoline)s are versatile polymers used in pharma-
ceutical applications.5 There are several naming conventions
given to poly(2-oxazoline)s in the literature, such as POZ, POx
and PAOx. Similar to poly(ethylene glycol) (PEG), a polymer fre-
quently used in formulations,6 they have “stealth” properties,
are non-toxic and biocompatible.7 POZ oﬀer several advantages
over PEG, such as facile synthesis,8 a pendent group available
for further functionalisation,8,9 a high degree of renal clearance
with no bioaccumulation,10 and improved stability against oxi-
dative degradation.11,12 Although not currently FDA approved,
there is extensive research using poly(2-oxazolines) for pharma-
ceutical applications, and it is expected to gain regulatory clear-
ance within the next few years.13 In fact, some POZ-based
formulations are currently undergoing clinical trials.14
The gastric mucosa provides a significant barrier to oral
drug delivery, including the overlying layer of glycoproteins
(mucins) that form a mesh-like structure that inhibits foreign
molecules, particles, and pathogens from reaching the under-
lying cells and systemic circulation.15 This highly viscous
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mucus gel comprises mucins, salts, and other biomolecules
and inhibits the penetration of hydrophobic compounds.16
Given that there are numerous literature reports on mucoadhe-
sive particles and polymers,17,18 the field of mucus-penetrating
nanoparticles has emerged in recent years and gaining rapid
popularity. It has been shown that, by functionalising nano-
particle surfaces with poly(ethylene glycol)19 or poly(vinyl
alcohol),20 it is possible to enhance their diﬀusion through a
mucosal barrier. Further, we have previously shown that poly
(2-ethyl-2-oxazoline) enhanced nanoparticle permeation
through a gastric barrier.21 Given the advantages that POZ has
over other polymers such as PEG, this may allow hydrophobic
drugs (which are commonly delivered by intravenous or sub-
cutaneous administration), to be delivered orally, thus improv-
ing patient compliance. In addition to this, other systems
have been studied including magnetic nanoparticles,22
poly(lactide)-PEG nanoparticles,23 and papain-modified
poly(acrylic acid) nanoparticles,24 demonstrating the diversity
of mucus-penetrating nanomaterials in the literature.
However, despite the popularity of mucus-penetrating nano-
particles, there are currently no systematic studies reporting
the influence of polymer structure on mucus penetration of
polymer decorated nanoparticles. Here, we demonstrate for
the first time that minor alterations to the alkyl side chain
length in POZ significantly aﬀects the diﬀusion and pene-
tration of functionalised nanoparticles through gastric
mucosa. By using 50 nm silica nanoparticles as a model,
known to be mucoadhesive in nature,25 any changes in
diﬀusion can be attributed to the architecture of the polymers
itself.
2. Materials and methods
2.1 Materials
3-Mercaptopropyltrimethoxysilane (MPTS), triethylamine
(TEA), and porcine gastric mucin type II were purchased from
Sigma-Aldrich (Gillingham, UK). Maleimide terminated Alexa
546, dimethyl sulphoxide, and fluorescein-O-methacrylate were
purchased from ThermoFisher Scientific (UK), and D2O from
VWR International (UK). Acetonitrile was from Acros (UK). All
other chemicals used in this study were of analytical grade and
purchased from Sigma-Aldrich (Gillingham, UK) unless other-
wise stated.
Water was ultrapure, from a Purelab UHQ water filter (Ω =
18). Propargyl benzenesulphonate was distilled prior to use.
2-Methyl-2-oxazoline, 2-ethyl-2-oxazoline and 2-n-propyl-2-oxa-
zoline (synthesised as previously reported26) were distilled over
barium oxide. Acetonitrile was dried over molecular sieves
(3 Å), and tetramethylammonium hydroxide in methanol
(25 wt%) was used as received.
2.2 Polymer synthesis
All reagents were stored and handled under dried nitrogen in
a glove-box (Vigor gas purification technologies, Inc.). Polymer
synthesis was as reported:27 a 4 M solution of the 2-alkyl-2-oxa-
zoline monomer was prepared in acetonitrile in the presence
of 1/50 equivalents of propargyl benzenesulphonate. The poly-
merisation mixture was heated to 100 °C in an aluminium
heating block for 60 min, according to previous reports,28
cooled to 0 °C and the living polymer chains were terminated
by addition of 1.1 equivalents of tetramethylammonium
hydroxide under a dry nitrogen atmosphere. The polymeris-
ation mixture was kept stirring for 18 hours at room tempera-
ture after which the solvent was evaporated under reduced
pressure. The polymer was re-dissolved in dichloromethane
and precipitated in cold diethyl ether, providing a white
powder that was filtered and dried in a vacuum oven at 50 °C
for 24 h. Polymer composition was confirmed by 1H-NMR
spectroscopy, MALDI-ToF MS and size exclusion chromato-
graphy. Full characterisation details of the polymers obtained
can be found in the ESI (Fig. S1†).
2.3 Polymer characterisation
1H-NMR spectra were recorded in CDCl3 on a Bruker Avance
300 MHz spectrometer. Spectra were processed using Bruker
software (TOPSPIN 3.0).
Size exclusion chromatography (SEC) was performed on an
Agilent 1260-series equipped with a 1260 ISO-pump, a 1260
Diode Array Detector, a 1260 Refractive Index Detector, using
two Mixed-D 30 cm columns (Agilent) and a Mixed-D pre-
column (Agilent) in series at 50 °C, with DMA containing
50 mM of LiCl as eluent, at a flow rate of 0.593 mL min−1.
Molar masses and dispersity values were calculated against
polymethylmethacrylate standards.
MALDI-ToF MS (Matrix-Assisted Laser Desorption and Ion-
isation Time of Flight Mass Spectrometry) used an Applied
Biosystems Voyager-DE STR instrument equipped with a nitro-
gen laser operating at 337 nm, pulsed ion extraction source
and reflectron detector. The laser pulse width was 3 ns with a
maximum power of 20 Hz. Spectra were recorded in reflector
mode with an acceleration voltage of 19 kV and delay of
400 ns. 100 single shot acquisitions were summed to give the
spectra and the data were analyzed using Data Explorer soft-
ware. Samples were prepared by dissolving the matrix 2-(4-
hydroxyphenylazo)benzoic acid (HABA) in the solvent (acetone,
20 mg mL−1), mixing with the polymer (1 mg mL−1) and
sodium iodide in acetone (15 mg mL−1) that was used as a
cationising agent.
2.4 Nanoparticle synthesis
Thiolated silica nanoparticles were synthesised according to
our previously published protocol.25,29 0.75 mL MPTS was
reacted with 0.5 mL NaOH (0.5 mol L−1) in 20 mL DMSO. The
reaction was left for 24 hours at room temperature whilst con-
tinuously bubbled through with air to aid disulphide bond for-
mation by partial oxidation of free thiol groups. After
24 hours, the particles were purified by dialysis, using a cell-
ulose dialysis membrane (12–14 kDa molecular weight cut-oﬀ,
Medicell International, UK). The dialysis membrane was
placed in a beaker containing 4 L deionised water. The water
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was changed, over a 48 hour period with a total of 10 changes.
Samples were stored at 4 °C until further use.
2.5 Determination of reactive thiol content and fluorescent
labelling
Before functionalisation, the concentration of reactive thiol
groups was determined by Ellman’s assay. Prior to the assay, 3 ×
1 mL suspensions of nanoparticles were lyophilised using a
Heto PowerDry LL3000 freeze drier and the dry weight recorded
to determine the initial particle concentration (mg mL−1). The
samples were then pooled for solid state analysis.
For Ellman’s assay;30,31 3 mg of dry particles were re-sus-
pended in 10 mL phosphate buﬀer (pH 8, 0.5 M), and allowed
to incubate for 1 hour. 10 aliquots (0.5 mL) were individually
placed in 1.5 mL Eppendorf tubes and reacted with 0.5 mL
5,5′-dithiobis-(2-nitrobenzoic acid) (0.3 mg mL−1) for 2 hours
in the dark. 200 µL aliquots were then placed into a 96 well
plate (three repeats for each Eppendorf tube), and the absor-
bance measured at 420 nm using a BioTek Epoch plate reader.
L-Cysteine–HCl solutions were used as standards from
3.125 µM to 12.69 µM.
Two diﬀerent fluorophores were used; maleimide termi-
nated Alexa 546, and fluorescein-O-methacrylate. The Ellman’s
assay showed that the free thiol content on the surface of the
unfunctionalised silica nanoparticles was 212 ± 47 µmol g−1;
consequently, 10 µmol of thiol groups were reacted with
fluorophore since it was previously shown that labelling 5% of
the nanoparticle surface was suﬃcient to allow particle visi-
bility above background fluorescence from mucins.21
For Alexa 546 labelling, 1 mg of dye was dissolved in 5 mL
water. From this, 200 µL of aqueous fluorophore was added to
a 2 mL aqueous suspension of nanoparticles (5 mg mL−1). The
suspension was left stirring overnight, and purified by dialysis,
as described in section 2.4.
For fluorescein labelling, a fluorescein-O-methacrylate solu-
tion (1.8 mM) was prepared in 50 : 50% v/v ethanol–deionised
water. From this, 2 mL was added to 5 mL of nanoparticles
suspended in DMSO (10 ± 0.5 mg mL−1) along with 200 µL
TEA (0.033 mM final concentration). The reaction was left to
stir in a flask for 24 hours in the dark. Labelled nanoparticles
were purified by dialysis, as described in section 2.4.
2.6 POZylation of nanoparticles
After fluorescent labelling, particles were functionalised with
POZ using a previously published protocol with minor modifi-
cations.21,32 A 5 mL aqueous suspension of nanoparticles was
diluted with 5 mL of DMSO. To this, 100 mg alkyne terminated
POZ and 200 µL TEA was added. The reaction was left for
96 hours at room temperature under constant stirring. Samples
were then purified by dialysis, as described in section 2.4.
2.7 Nanoparticle characterisation
Following functionalisation, nanoparticles were characterised
for size using dynamic light scattering (DLS) and nanoparticle
tracking analysis (NTA), for surface functionality using FT-IR and
FT-Raman spectroscopy, and for polymer loading using thermo-
gravimetric analysis (TGA). Small Angle Neutron Scattering
studies were used to determine the corona (and core) sizes.
Transmission electron microscopy (TEM) images were also taken.
DLS measurements were performed using a Zetasizer Nano-
ZS (Malvern, UK). Samples were diluted 1 : 100 with ultrapure
water to appropriate concentrations in low volume plastic cuv-
ettes (Fisher Scientific, UK). A refractive index of 1.49 and
absorbance of 0.1 was used for all recordings. Individual
measurements were carried out for 10 seconds per run, with
12 runs per reading, repeated in triplicate. This was repeated for
3 separate samples at 25 °C. ζ-Potential values were also
measured, using DTS-1070 folded capillary tube cuvettes
(Malvern, UK). Samples were prepared to the same concen-
tration as for sizing experiments and injected into the cuvettes
ensuring no air bubbles were present. Samples were analysed
using 20 sub-runs per reading, repeating 3 times for each
sample. Each sample was measured three times and the results
were processed using the Smoluchowski model (Fκa = 1.50).
NTA measurements used an LM10 system with temperature
controlled module, green 532 nm laser, and syringe pump
(Malvern, UK). NTA requires very low concentrations of nano-
particles in suspension, as each nanoparticle is individually
tracked. Therefore, samples were initially diluted 1 : 10 000 and
adjusted until appropriate concentrations were found. Samples
were placed in a 1 mL syringe, loaded into the system and the
NTA syringe pump set to a flow rate of 30 AU. Videos were
recorded for 60 seconds. 5 videos were collected per individual
sample, and triplicate samples were recorded. Analysis used
NTA v3.0 software. All NTA sizing experiments were performed
at room temperature (25 °C) under the constant flow from the
syringe pump, to obtain data representative of the dispersions.
Experiments to assess surface functionality and polymer
loading were carried out with lyophilised nanoparticles. FTIR
spectra were recorded using a Spectrum 100 FTIR spectro-
photometer (Perkin Elmer, UK). Spectra are the average of 32
scans, between 4000 and 550 cm−1, at a resolution of 4 cm−1.
FT-Raman spectra were recorded on a Nicolet NXR 9650
Raman spectrophotometer (Thermo Scientific, UK) as an
average of 1000 scans, between 4000 and 10 cm−1, at a resolu-
tion of 4 cm−1.
Thermogravimetric analysis (TGA) was performed on a
Q500 instrument (TA Instruments, UK) with nitrogen as the
inlet gas. Baselines were taken against an empty platinum TGA
pan and Tzero aluminium DSC pans (TA Instruments, UK).
Samples were placed into an aluminium DSC pan, before
being loaded into the platinum TGA pan on the instrument.
The initial temperature was set to 35 °C, and allowed to equili-
brate for 5 minutes. Thermal decomposition was measured as
the temperature ramped from 35 to 500 °C at 10 °C min−1.
TEM images were recorded using a Phillips CM20 analytical
TEM, with an accelerating voltage of 200 kV and a 4 megapixel
AMT camera. Samples were prepared by placing a drop of nano-
particle suspension onto a section of parafilm. A Holey Carbon
film 300 mesh copper grid (HC300Cu, EMResolutions, UK) was
then placed onto the drop and left for a minute. The grid was
then left to air dry before being placed in the instrument.
Paper Biomaterials Science
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2.8 NMR spectroscopy
Solid state NMR spectroscopic analysis was carried out using
freeze-dried thiolated silica and poly(2-ethyl-2-oxazoline) deco-
rated silica nanoparticles. The 29Si solid state NMR spectra
were recorded on Bruker 500 MHz Avance III spectrometer at a
Larmor frequency of 99.35 MHz (11.75 T) for 29Si. Both single
pulse (SP) and cross-polarisation magic angle spinning
(CPMAS) spectra were recorded. The standard bore 4 mm MAS
probe was spun at 10 kHz. The 29Si 90° pulse length was
6.25 µs (at the power level of 67.86 W) and the relaxation delay
time was 150 s for all SP experiments. For all CPMAS experi-
ments, the 1H 90° pulse length was 3.7 µs (at the power level
of 38 W), the CP contact time was 3 ms and the relaxation
delay time was 5 s. Between 500 and 4096 signal transients
were accumulated and averaged into a single spectrum. All
spectra were referenced to external kaolinite signals as a sec-
ondary reference (well resolved peaks at −90.0 ppm and
−91.4 ppm with respect to TMS).
2.9 SANS
Small angle neutron scattering (SANS) experiments were per-
formed on the D11 instrument at the Institute Laue-Langevin
(Grenoble, France). The detector distance and flux were set in
order to assess the core–shell structure of the functionalised
and unfunctionalised nanoparticles across a large Q range,
defined by eqn (1), where θ is the incidence angle, and λ is the
neutron wavelength;
Q ¼
4π sin
θ
2
λ
ð1Þ
Prior to SANS experiments, both functionalised and
unfunctionalised nanoparticles were dialysed into D2O using a
7 kDa molecular-weight cut-oﬀ membrane (Medicell Inter-
national, UK). This was carried out to remove the incoherent
scattering obtained from particles suspended in H2O. A 2 mL
suspension of particles (5 mg mL−1) was dispensed into the
membrane and sealed, before being placed into a vial contain-
ing ∼30 mL D2O. D2O was replaced every 6 hours with a total
of 3 changes. Following dialysis, samples were stored in glass
vials, sealed with parafilm at 4 °C. For SANS experiments,
samples were diluted 1 : 10 into D2O, placed into quartz 700 µL
Hellma cuvettes and sealed with a PTFE stopper. Samples were
then placed in the beam-line. An incident wavelength of 8 Å
was used and 3 detector distances of 1.2 m, 8 m and 28 m
were used to cover a large Q-range from 2 × 10−3 to 0.3 Å−1
(DOI: 10.5291/ILL-DATA.9-12-422).
Data was fitted using the SasView programme (http://www.
sasview.org). Both DLS and TEM data were used to define the
core particle diameter and polydispersity index (PDI). A scatter-
ing length density (SLD) of 3.2 × 10−6 Å−1 was used for the core
silica, based on previous SANS experiments using these par-
ticles,33 along with an SLD of 6.23 × 10−6 Å−1 for the nano-
particle corona. Initially scattering profiles were fitted to a
spherical model (built into the software with no further modi-
fication), followed by a core–shell form to determine the thick-
ness of the corona.
2.10 Nanoparticle diﬀusion
Diﬀusion experiments used the NTA LM10 system described
above for size measurements. Prior to analysis, 3 × 25 mL
gastric mucin type II dispersions (1% w/v) in ultrapure water
were prepared, and left to stir overnight to ensure complete
hydration. Alexa 546 labelled nanoparticles were diluted by a
factor of 1 : 100 to form a stock solution. 10 µL of these sus-
pensions was then added into 1 mL of the mucin dispersion
for analysis, resulting in a total dilution of 1 : 10 000.
Samples were injected into the NTA system and the flow-
rate set to 50 AU in order to minimise fluorescent bleaching of
the nanoparticles during analysis. All videos were recorded
through a 565 nm cut-on filter. 6 × 60 second videos were
recorded at 25 and 37 °C for each sample. Each independent
dispersion of mucin was employed three times with each
nanoparticle type, resulting in a total of 9 × 6, 60 second
videos for each temperature. A viscosity of 25 cP at 25 °C and
28 cP at 37 °C was used for analysis.21
2.11 Mucosal penetration and histology
The mucus penetration study was carried out according to a
previously published protocol, with minor modifications.21
Fresh porcine stomach was obtained from a local abattoir
(P.C. Turner Abattoirs, Farnborough, UK), and dissected to
remove connective tissue and muscle, leaving only the
mucosa, submucosa, and stomach lining intact. 4 × 1 cm2 sec-
tions were cut and placed on a glass plate, with the mucosal
layer facing upward. 200 µL of fluorescein labelled nano-
particles were pipetted onto the sections; deionised water was
also administered as a (blank) control. Samples were left to
incubate for 0, 15, 30, 45, and 60 minutes at 37 °C. Following
each time point, tissue sections were placed mucus side up
into a small (3.5 × 5.5 cm) weighing boat (Fisher Scientific,
UK), half filled with OCT, a cryoprotective embedding
medium. They were then placed on dry ice, before being com-
pletely embedded in OCT to preserve the particle-loaded
mucus membrane. Once all sections were embedded, samples
were left on dry ice for 3–4 hours, before storage at −80 °C
until processing.
For sectioning, samples were removed from the −80 °C
freezer and placed on dry ice. Each sample was mounted onto
a 22 mm standard solid object holder using OCT, and placed
on dry ice for 30 min until completely frozen. 20 µm sections
were cryosectioned transversely using a standard 189 × 27 ×
10 mm blade at 22°, placed onto superfrost charged slides
(Life Technologies, UK) and left to air dry for 30 minutes
before being stored in a slide box. All sections were cut from
interior to exterior (i.e. upwards through the mucosal layer) in
order to avoid carriage of particles into the biological tissue
during cutting. All sections were cut using a Bright 5040 cryo-
stat in a Bright Model PTF freezing chamber at −20 °C (Bright
Instrument Co. Ltd, UK).
Biomaterials Science Paper
This journal is © The Royal Society of Chemistry 2016 Biomater. Sci., 2016, 4, 1318–1327 | 1321
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
1 
Ju
ly
 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
9/
08
/2
01
6 
09
:3
0:
42
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
Sections were placed under a Leica MZ10F stereomicro-
scope (Leica Microsystems, UK). All images were taken through
an ET-GFP filter (Leica Microsystems, UK) using an exposure
time of 0.8 ms. 10 images were taken for each particle type, at
each time point from a separate section of tissue.
ImageJ software (National Institute of Health, USA, v1.43)
was used to quantify penetration of the nanoparticles. For
each image, the background was subtracted, a line drawn
across the mucus barrier, and the “plot profile” measured.
A diagrammatical representation of this process can be found
in ESI (Fig. S2†). This was repeated 5 times at random
locations along the mucosal barrier for each image, providing
a total of 50 (10 × 5) profiles for each sample. Each individual
profile was then assessed for fluorescent particle penetration
using the width of the predominant peak. After each profile
had been analysed, mean thickness was then calculated for
each sample. Auto fluorescence was corrected for using values
from the blank (water control) treated tissue at the appropriate
time point, subtracted from the nanoparticle treated values.
In addition to fluorescence microscopy, histology of the
stomach mucosa was carried out. Sections were initially
immersed in a 1% v/v hematoxylin solution for 5 minutes. The
samples were then washed with deionised water to remove
excess solution, followed by a wash with 0.1 M HCl in ethanol
for 10 seconds and a final wash with deionised water. The
section was then counterstained with 1% v/v eosin for
2 minutes before a final washing step with deionised water
and left to dry. Samples were examined under a light micro-
scope (Leica DM2500 M, Leica, UK), and images obtained
using an Infinity 1-1C camera (Lumenera, UK).
2.12 Statistics
Statistical analysis used GraphPad Prism, v 5.0. Means ± stan-
dard deviations were determined and assessed for significance
using 2-way ANOVA with a Bonferoni post hoc test. Values of
p < 0.05 were considered to be significant.
3. Results and discussion
3.1 Nanoparticle characterisation
Here, we report that systematic variation of the alkyl side chain
length of POZ grafted on nanoparticle surfaces radically alter
their penetration into and diﬀusion through a gastric mucosal
barrier. These structural modifications have minimal impact
on the particles’ sizes, surface charge, or free thiol contents.
The thiolated silica nanoparticles were monodisperse (PDI
< 0.1), and contained a high concentration of reactive thiol
groups for further functionalisation and fluorescent labelling.
The particles were functionalised with 3 diﬀerent variants of
POZ; poly(2-methyl-2-oxazoline) (PMOZ), poly(2-ethyl-2-oxazo-
line) (PEOZ), and poly(2-n-propyl-2-oxazoline) (PNPOZ). The
reaction mechanism for grafting is shown in Fig. 1; the TEA
hydrogen bonds to the hydrogen atom in the thiol, generating
a stronger nucleophile that attacks the reactive alkyne species
on the terminal group of the polymer, forming a covalent
bond between the two. It is possible (dependent on the proxi-
mity of the thiol groups to each other) that the resulting
alkene formed in the reaction can further react with a thiol
group, eliminating all double bonds in the system. However,
this secondary reaction is highly dependent on the proximity
of the thiol groups, and therefore unlikely, while it will not
influence the grafting eﬃciency nor grafting density.
Immediately following synthesis and purification, the par-
ticles were sized using DLS and NTA, their surface functional-
ity assessed using FT-IR and FT-Raman spectroscopy, and
polymer loading determined using TGA. The DLS size distri-
butions (ESI, Fig. S3†) show that, as expected, upon functiona-
lisation particle size increases, suggesting successful
conjugation. Further DLS information (PDI and ζ-potential)
and NTA (size and diﬀusion coeﬃcient) can be found in
Table 1. In addition to size analysis, the particles were tested
for their functionality by FT-IR and FT-Raman. Fig. 2a shows
the FT-IR spectra for the functionalised and unfunctionalised
nanoparticles, and the Raman spectra can be found in Fig. 2b.
All spectra show strong vibrational modes at ∼1032 and
∼1102 cm−1, consistent with Si–O–Si stretching from disilox-
ane in the nanoparticle core. Due to the complex nature of the
siloxane moiety in the nanoparticles (either Si–O–Si–O–Si, or
C–O–Si–O), additional stretching modes appear as relatively
weak features between 1300 and 1000 cm−1.34 Other minor
modes from the silica core are seen at 2923 cm−1 (C–H
stretch), 1237 cm−1 (C–O stretch), and 687 cm−1 (Si–S stretch).
The nanoparticle structure proposed by Irmukhametova
et al.25 is in agreement with these spectral features.
Upon functionalisation, the spectra for POZ-silica show
modes attributed to the polymer; 2978 cm−1 (CH2 stretch),
1629 cm−1 (CvO stretch), 1463 cm−1 (C–H deformation),
1416 cm−1 (CH3 symmetrical deformation/CH2 bending), and
1236 cm−1 (C–N stretch). The spectra for the diﬀerent polymer
variants (PMOZ, PEOZ, and PNPOZ) essentially show the same
molecular modes, most noticibly the strong CvO stretching
mode around ∼1630 cm−1. These features confirm the pres-
ence of POZ in the samples, and successful conjugation of the
polymer to the particle surface.
Additionally, the molecular modes were investigated by
FT-Raman spectroscopy (Fig. 2b). For thiolated silica (blue),
there are characteristic Raman peaks at 2898 cm−1 (C–H),
2555 cm−1 (S–H), 1406 cm−1 (CH2), 1294 cm
−1 (C–C),
1242 cm−1 (C–C), 627 cm−1 (C–S), and ∼500 cm−1 (Si–O–Si and
S–S). After functionalisation with PMOZ, PEOZ, and PNPOZ
Fig. 1 Proposed reaction mechanism for the functionalisation of silica
nanoparticles by POZ.
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there are two notable changes to the spectra; firstly a decrease
in the intensity of the peak at 2555 cm−1 (S–H stretch),
suggesting a decrease in the number of reactive thiol groups
(confirmed with Ellman’s assay), and secondly the emergence
of two new features at 1631 cm−1 (CvO stretch), and
1024 cm−1 (C–C stretch). The emergence of these two peaks
further confirms successful conjugation of POZ to the surface
of the nanoparticles.
TGA was used to assess polymer loading on the silica par-
ticles. Weight loss during thermal decomposition (between
350 and 400 °C) showed that the polymer accounted for
29–37% of the nanoparticle weight (Table 1). TGA curves can
be found in Fig. S4. To show that comparable amounts of
polymer were grafted to the nanoparticles in all cases, the
grafting density was determined. Grafting densities of 0.13,
0.11, and 0.12 µg nm−2 were calculated for PMOZ, PEOZ, and
PNPOZ, respectively. It can therefore be concluded that com-
parable amounts of polymer were grafted to the nanoparticles
in each case, ensuring any changes in diﬀusion coeﬃcient/
mucus penetration were due to changes in side-chain structure
of the polymer and not grafting density.
3.2 NMR spectroscopy
NMR spectroscopic studies were undertaken to further
confirm successful surface modification and, importantly, to
also confirm that decorating the nanoparticle surfaces had no
adverse eﬀects on the silica core dimensions. Fig. 3 shows the
CPMAS NMR spectrum of the silica precursor, highlighting two
peaks at −57.9 ppm and −67.8 ppm. These resonances are attribu-
ted to the 29Si nuclei at three and two silicon–oxygen–silicon
bridge coordination (so called T3 and T2 species), respectively.35
The SP and CPMAS spectra do not show any significant diﬀerences
and yield similar intensity ratios IT3/IT2 of ca. 8.6.
Fig. 4 compares CPMAS spectra of the thiolated nano-
particles and PEOZ functionalised silica. The resonance at
−67.8 ppm remains unchanged whereas the peak at
−57.9 ppm shifts upfield to −58.9 ppm after functionalising
the surface of the silica nanoparticles with PEOZ. The intensity
ratio IT3/IT2 decreases from ca. 8.6 for the SP experiment, to
ca. 7.6 for the CPMAS experiment. The increase in the T2
intensity suggests proximity of additional protons which will
Table 1 Physicochemical properties for functionalised and unfunctionalised silica nanoparticles. All values are the means of 3 repeats ± standard
deviation
Nanoparticle
z-Averagea
(nm) PDIa
ζ-Potentiala
(mV)
Mode diameterb
(nm)
Diﬀusion coeﬃcient in
waterb (×104 nm2 s)
Concentration of
polymerc (%)
Free thiol
(µmol g−1)
Thiolated silica 52 ± 1 0.072 −46 ± 2 54 ± 1 788 ± 20 0 212 ± 47
PMOZ-silica 61 ± 4 0.188 −23 ± 1 61 ± 4 811 ± 33 29 24 ± 6
PEOZ-silica 59 ± 1 0.106 −20 ± 2 59 ± 1 798 ± 2 37 27 ± 3
PNPOZ-silica 61 ± 1 0.194 −21 ± 2 63 ± 3 787 ± 28 33 14 ± 1
a Shows values determined by DLS. b Shows values determined by NTA. c Shows values determined by TGA.
Fig. 2 (a) FT-IR and (b) FT-Raman spectra for thiolated silica (blue), and
functionalised silica nanoparticles.
Fig. 3 MAS NMR spectra of thiolated silica; one pulse spectrum is
shown in red, CPMAS spectrum is shown in blue.
Biomaterials Science Paper
This journal is © The Royal Society of Chemistry 2016 Biomater. Sci., 2016, 4, 1318–1327 | 1323
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
1 
Ju
ly
 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
9/
08
/2
01
6 
09
:3
0:
42
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
cause enhancement of the signal in the CPMAS experiment.36
Both the upfield shift and increase in the intensity of the T2
signal are consistent with the presence of the PEOZ molecules
(additional source of protons) on the nanoparticle surface.
The changes to the T2 resonance suggest that Si–O–Si
bridges are predominantly present on the surface of the nano-
particle and are thus more sensitive to its modification.
Assuming that the nanoparticles are spherical (as shown by
TEM) and that T2 species are present only on the surface, the
radius of the nanoparticle can be estimated. The intensity
ratio IT3/IT2 (the core and surface silica) can provide a crude
estimate of the size because the ratio of the volume to the
surface area of sphere changes as the function of its radius.
The unfunctionalised thiolated silica nanoparticle had a
radius estimated to be ca. 26 nm (both from SP and CPMAS
experiments), and the PEOZ functionalised nanoparticles had
an estimated core radius also of ca. 26 nm. Both sizes appear
the same because there are no changes to the number of
silicon moieties on the surface, and the single pulse experi-
ment does not rely on signal enhancement (proton-carbon
cross-polarisation transfer). With the CPMAS experiment, the
estimated size is smaller ca. 23 nm, as expected for the
enhanced T2 signal intensity. These sizes are in good agree-
ment with the DLS data; however, the DLS shows that the Dh
of the particles is 52 nm, including the hydrated polymer
chains. As the size determined by NMR spectroscopy is in the
solid-state (and therefore not in the presence of water) and
only takes into account the silica particle and not the polymer
chains, it would be expected that the size would be smaller.
However, this is not the case. It is likely that the freeze-drying
process causes this discrepancy, as water diﬀusing into the
core of the nanoparticle would freeze forming ice crystals,
which would warp the internal structure of the particle, thus
creating pockets of empty space which would result in a larger
particle size. A similar result was reported previously,37,38
where the size of suspended silica nanoparticles was larger
than the original particle size after lyophilisation, without the
presence of any cryoprotectants.
3.3 SANS analysis
Small angle neutron scattering can probe both the external
and internal structure of nanoparticles. Previously we have
employed SANS to look at the core–shell structure of PEGylated
silica nanoparticles.33 Here, SANS was used to determine the
structure of functionalised silica nanoparticles and to confirm
that decorating the particle surface with POZ has no detrimen-
tal eﬀects to the core particle itself.
The scattering profiles for these particles are shown in
Fig. 5; curve fitting for each is given in ESI (Fig. S4†). The scat-
tering profile for thiolated silica was initially fitted to a spheri-
cal form factor, using DLS and TEM data as a guide. The
particle was found to have a radius of 137 Å, resulting in a dia-
meter of 28 nm, which is significantly (P < 0.05) smaller than
the size determined by DLS (52 nm) but is in good agreement
with the NMR data. Previous studies by Mun et al.33 (who
studied the core–shell structure of PEGylated MPTS silica
nanoparticles) showed sizes of 30 nm for these particles using
SANS. The discrepancy between SANS data with that from light
scattering is due to the presence of a solvation shell around
the particle, which is detected by DLS, but not by SANS. Due to
the abundance of surface –SH and –Si–O− groups, there are
strong interactions between water molecules and the nano-
particle surface, leading to a relatively large hydration shell.
Upon functionalisation, only minor changes in the scatter-
ing pattern arise (at high Q values ∼0.03 Å−1). A study of the
swelling behaviour of PMOZ and PEOZ showed that POZ
macromolecules are highly hydrated and bind tightly to water,
and that PMOZ was significantly more hydrated than PEOZ.39
This phenomenon explains why the shell is barely visible
using SANS; it is highly hydrated and oﬀers no contrast to the
D2O background, and so cannot be seen. It was found during
curve fitting that changing the size of the shell (in a core–shell
model) did not aﬀect the curve. Based on this, the particles
were fitted to a spherical form-factor, and displayed a size of
28 nm for all particles. With no significant change in size or
Fig. 4 The CPMAS NMR spectra of thiolated silica (blue) and
PEOZylated silica (red).
Fig. 5 SANS proﬁles for thiolated silica (blue), PMOZ-silica (red), PEOZ-
silica (green), and PNPOZ-silica (purple) nanoparticles. The insert shows
the TEM image for unfunctionalised thiolated silica, used for the ﬁtting.
The scale-bar represents 100 nm.
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scattering observed, it can be concluded that the addition of
the polymer shell does not change the nanoparticles core
architecture during the functionalisation reaction.
Although the SANS data could not be fitted to a core–shell
model, the size of the hydrated polymer shell can be esti-
mated. From the SANS data, the core diameter is 28 nm. Light
scattering sizes include the hydration shell and provide a dia-
meter of 52 nm for the thiolated particles; from this, a
hydration layer of ∼13 nm for the non-polymer coated particles
can be postulated. The particle diameters from DLS data in
Table 1 for the functionalised nanoparticles then indicate
shell thicknesses of 4, 3, and 5 nm for PMOZ, PEOZ, and
PNPOZ, respectively. Similar values have been reported in the
literature for PMOZ functionalised silica.40 It should be noted
that these sizes are estimates based on the diﬀerence in
hydration shell thickness. Clearly it is feasible that some
polymer is present within the hydration shell, which would
suggest a larger shell thickness.
3.4 Diﬀusion through a mucus dispersion
Previously we used nanoparticle tracking analysis to measure
the diﬀusion of fluorescently labelled nanoparticles through
solutions of polymers,33 and mucin dispersions.21 Here, POZ
decorated nanoparticle diﬀusion coeﬃcients were measured in
1% w/v gastric mucin dispersions at 25 and 37 °C; Fig. 6
shows the mean ± SD values for functionalised and unfunctio-
nalised nanoparticles.
The diﬀusion coeﬃcients vary radically with only minor
alterations to the POZ alkyl side groups. The unfunctionalised
thiolated particles are mucoadhesive in nature, and correlate
with the diﬀusion coeﬃcients determined in our previous
study. Upon functionalisation, the PMOZ-coated particles are
significantly more diﬀusive than the unfunctionalised par-
ticles and also have a significantly higher diﬀusion coeﬃcient
than PEOZ-coated particles (p < 0.05), at both temperatures.
PEOZ-particles are also significantly more diﬀusive than the
unfunctionalised particles (p < 0.05), although to a lesser
degree. PNPOZ-silica nanoparticles were no more diﬀusive
than the unfunctionalised particles (p > 0.05). The trend to
decreasing diﬀusion coeﬃcient with the addition of methylene
bridges in the polymer can be ascribed to less eﬃcient
hydration and was corroborated by studies evaluating pene-
tration of the nanoparticles into gastric mucosa.
3.5 Penetration into gastric mucosa and tissue histology
In order to assess penetration of the functionalised nano-
particles into gastric mucosa, fluorescence microscopy was
employed. The summarised data in Fig. 7 illustrates that
PMOZ-silica particles are significantly more diﬀusive than
both PEOZ, and PNPOZ functionalised silica (p > 0.05) at all
time points, a relationship that was found to be linear with
time (with R2 values of 0.95, 0.98, and 0.92, respectively,
Fig. S5†). The variance in rate of penetration accords with the
diﬀusion coeﬃcients for the particles in the mucin dispersion
(Fig. 6). As the alkyl chain length increases (from methyl to
propyl) there is a significant (P < 0.05) change in both pene-
tration and diﬀusion coeﬃcient of PMOZ and PEOZ-silica
nanoparticles, again a trend which was found to be linear
(R2 = 0.9975, Fig. S6†). For PNPOZ-silica nanoparticles, there is
no significant diﬀerence in diﬀusion coeﬃcient to the un-
modified silica particles, however there is a significant diﬀerence
observed in their mucosal penetration at longer time periods.
This is attributed to interactions between the mucus and the
particles. Although the diﬀusion coeﬃcients of the nano-
particles in the mucin dispersions are similar (77 ± 6 or 51 ± 8 ×
104 nm2 s for thiolated silica and PNPOZ-silica, respectively), the
thiolated silica is highly mucoadhesive and will therefore bind
to the mucosal surface and hence its penetration is retarded as
illustrated in Fig. 7. PNPOZ however is less mucoadhesive; the
functionalisation greatly reduces the nanoparticles surface thiol
groups that are responsible for mucoadhesion and so the par-
ticles permeate through the mucus, although slower than the
other POZylated particles.
Based on the physicochemical characterisation data and
previous reports, the diﬀerence in diﬀusion coeﬃcient and
Fig. 6 Diﬀusion coeﬃcients for thiolated, and POZylated silica nano-
particles through a 1% gastric mucin dispersion at 25 and 37 °C. Error
bars represent the mean ± standard deviation of 3 repeats.
Fig. 7 Penetration of thiolated and functionalised silica nanoparticles
over 1 hour. Values represent the mean penetration across 10 separate
tissue sections ± standard deviation.
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penetration is likely due to the hydration of the polymer.
PMOZ is significantly more hydrated than PEOZ, with PNPOZ
being the least hydrated of the series. Thus, the hydrophobicity
of the polymer grafted onto the surface of a nanoparticle is a
major factor in the penetration of surface modified nano-
particles through mucus barriers, and so minor structural
alterations can have unexpectedly large impacts. There are other
factors which could aﬀect this process (such as size), however
these were corrected for as much as possible. It is well known
that hydrophobic molecules are poorly penetrating through
mucosal barriers,16 and our data are consistent with this eﬀect.
In fact, PMOZ is more hydrophilic than PEG,41 whereas PNPOZ
exhibits a lower critical solution temperature (LCST) behaviour
at 25 °C.26 Based on the data presented here, and the findings
of our previous work,21 PMOZ appears to facilitate transmucosal
diﬀusion to a greater extent than PEG.
To confirm the eﬀect of polymer hydrophobicity on mucus
penetration, the hydrophobic–hydrophilic balance (HHB) was
calculated for each polymer, using the equation described in
ref. 42. Values of 5.0, 6.0, and 7.1 were calculated for PMOZ,
PEOZ and PNPOZ, respectively; showing the hydrophobicity
changes with increased alkyl chain length.
Enhanced diﬀusion by polymer-functionalised nano-
particles through mucus has been attributed to “stealth pro-
perties”. However, our study shows that if a polymer is
designed to be highly hydrophilic as well as containing
“stealth” properties, the diﬀusion of the particles will be sig-
nificantly enhanced. The thiolated silica nanoparticles them-
selves do not show any mucopenetration, and are well known
to be mucoadhesive in nature,43 as was also shown in a pre-
vious study.21
In addition to fluorescence microscopy, some sections of
stomach mucosa (chosen at random) were subjected to histo-
logical analysis. Fig. 8 shows representative images of the
penetration of PEOZ functionalised nanoparticles into fresh
porcine mucosa over time. Sections of a porcine stomach were
stained with hematoxylin and eosin, and images were taken
under a fluorescence microscope. Additional fluorescent
images can be found in the ESI Fig. SI.7† for each particle type
used in the penetration study.
Fig. 8 shows the histology of a porcine stomach lining, with
the gastric pits and underlying muscle tissue evident. From
the fluorescent images at 60 min (Fig. 8E) nanoparticle pene-
tration into the gastric pits can be seen.
These data correlate with the diﬀusion coeﬃcients deter-
mined using NTA, and show that the addition of a single CH2
group onto the alkyl side chain of polymer-functionalised
nanoparticles can have dramatic eﬀects on the diﬀusion coeﬃ-
cient of the particles.
4. Conclusions
This study is the first to report on the systematic modification
to alkyl side-chain length in nanoparticle diﬀusion. It provides
a fundamental framework in the future design of mucus pene-
trating systems, by showing that increasing the hydrophilicity
of the POZ macromolecule causes the particles diﬀuse signifi-
cantly faster through a mucus dispersion, and as a result pene-
trate further through a mucosal barrier. The addition of single
methylene groups to the polymer side-chain was found to
induce a linear decrease in permeation and diﬀusion coeﬃ-
cient. The hydrophobicity of polymers decorating nano-
particles is a major influence in their diﬀusion through
mucous and their mucosal penetration.
It should be noted that in this study, silica nanoparticles
were used as a model system due to their facile synthesis,
monodisperse nature, and high abundance of reactive thiol
groups for further modification. However, POZ could be
readily grafted to other particle types, such as lipid nano-
carriers for enhanced drug delivery, or gold nanoparticles/
quantum dots for mucus-penetrating bioimaging.
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